Lanean...
Perspectives: Other ErbB2-Targeted Therapies
SUMMARY: Despite the success of individualized targeted therapies in women with breast cancer with current available compounds, new drugs – especially with different mechanisms of resistance – are under development. A range of novel targeted agents for women with tumors that overexpress ErbB2 (HER2)...
Gorde:
| Egile nagusia: | |
|---|---|
| Formatua: | Artigo |
| Hizkuntza: | Inglês |
| Argitaratua: |
S. Karger GmbH
2010
|
| Gaiak: | |
| Sarrera elektronikoa: | https://ncbi.nlm.nih.gov/pmc/articles/PMC2931098/ https://ncbi.nlm.nih.gov/pubmed/20847930 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1159/000285779 |
| Etiketak: |
Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!
|